Archive

Daraxonrasib Pancreatic Cancer Pill nearly doubled survival in metastatic PDAC, beating second-line chemo with fewer discontinuations.

Medical scheme financial pressure intensifies as healthcare costs, an ageing population, and a R11.64bn operating deficit squeeze the sector.

The excessive Dialysis Product Pricing case targets Adcock Ingram, with a possible 10% turnover penalty and wider renal care cost impacts.

Learn about workplace mental health and the pressing need for companies to tackle stress and anxiety at work.

The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections.

South Africa’s Suicide Rate hits 21.1 per 100,000. New warnings highlight a rising burden, big productivity losses, and policy action.

Dis-Chem Franchise Expansion accelerates as the group targets 500 independent pharmacy conversions to boost market share.

SA pharma localisation faces hurdles as Trade Minister warns against foreign investor conditions that undermine domestic procurement.

Life Healthcare Expansion Plans include adding beds, new labs, and specialists as the group targets higher occupancy across its SA network.

The Constitutional Court’s decision against National Health Insurance opens new avenues for healthcare reform in South Africa.

Stay updated on the South African retail pharmacy scene as Clicks and Dis-Chem battle it out with innovative strategies for consumer loyalty.